(Q42110835)

reason for preferred rank

16 October 2017

title

Expression of HLA-D subloci DR and DQ by breast carcinomas is correlated with distinct parameters of favourable prognosis (English)

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

4 December 2022

Expression of HLA-D subloci DR and DQ by breast carcinomas is correlated with distinct parameters of favourable prognois (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1828168

4 December 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

4 December 2022

author name string

Riethmüller

3

1 reference

16 October 2017

C. A. Brunner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1828168

4 December 2022

J. M. Gokel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1828168

4 December 2022

J. P. Johnson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1828168

4 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1828168

4 December 2022

publication date

1 January 1991

1 reference

full work available at URL

16 October 2017

https://api.elsevier.com/content/article/PII:027753799190374M?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

https://api.elsevier.com/content/article/PII:027753799190374M?httpAccept=text/plain

4 December 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

European Journal of Cancer

4 December 2022

published in

1 reference

16 October 2017

volume

27

1 reference

16 October 2017

issue

4

1 reference

16 October 2017

page(s)

411-416

1 reference

T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex

16 October 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides

4 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

Human class II major histocompatibility complex genes and proteins

4 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

Phenotypic dynamics of tumor progression in human malignant melanoma

4 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

Tumor progression in human malignant melanoma: five stages defined by their antigenic phenotypes

4 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx

4 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

Expression of HLA-D sub-region products on human colorectal carcinoma

4 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease

4 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

Gene products of the HLA-D region in normal and malignant tissues of nonlymphoid origin

4 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

Immunohistochemical analysis of HLA antigens and mononuclear infiltrates of benign and malignant breast

4 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

P53 expression in breast cancer

4 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

Monoclonal antibodies in diagnostic pathology: techniques and applications

4 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

Sensitivity and optimal performance in steroid receptor analysis.

4 December 2022

15

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

Analysis of antigen presentation using HLA transfectants

4 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

Characterization and expression of the HLA-DC antigens defined by anti-Leu 10

4 December 2022

19

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

Detection of a novel human class II HLA antigen

4 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

Characterization of a monoclonal anti-beta 2-microglobulin antibody and its use in the genetic and biochemical analysis of major histocompatibility antigens

4 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis

4 December 2022

22

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

Progesterone receptors as a prognostic factor in Stage II breast cancer

4 December 2022

24

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

Cathepsin D: an independent prognostic factor for metastasis of breast cancer

4 December 2022

27

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

Correlations of the receptor content and ultrastructure of breast cancer cells

4 December 2022

28

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

Induction of HLA class-II antigen expression on human carcinoma cell lines by IFN-Gamma

4 December 2022

29

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

Hormonal regulation of the expression of Ia antigens on mammary gland epithelium.

4 December 2022

30

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

The localization of prolactin binding sites in human breast tissue

4 December 2022

33

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

Prolactin and breast cancer

4 December 2022

34

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

Abrogation of metastatic properties of tumour cells by de novo expression of H–2K antigens following H–2 gene transfection

4 December 2022

35

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigen in humans

4 December 2022

37

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

H-2-controlled suppression of T cell response to lactate dehydrogenase B. Characterization of the lactate dehydrogenase B suppressor pathway

4 December 2022

38

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

Immune response gene function correlates with the expression of an Ia antigen. II. A quantitative deficiency in A(e):E(a), complex expression causes a corresponding defect in antigen-presenting cell function

4 December 2022

39

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

Effect of the AIR-1 locus on the activation of an enhancerless HLA-DQA1 promoter

4 December 2022

41

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90374-M

4 December 2022

Identifiers

1 reference

16 October 2017

1 reference